Completed research + results
Making sustained progress in understanding, treating and ultimately curing leukemia requires advances across multiple areas, including cancer cell biology, causes and risk factors, treatments, and relapse prevention. Each year recipients of the Leukemia Research Foundation’s New Investigator Award contribute to those advances through their innovative research projects. Explore below the results and impact of recently completed research.
Hussein Abbas, MD, PhD
The University of Texas MD Anderson Cancer Center
Grant awarded: 2022
Disease: Leukemia (AML)
Research focus: Causes/risk factors (MDS)
Emanuele Azzoni, PhD
University of Milano-Bicocca
Grant awarded: 2021
Disease: Leukemia (JMML)
Research focus: Cancer cell biology (leukemia stem cells)
Timothy Barrow, PhD
University of Essex
Grant awarded: 2022
Disease: Chronic lymphocytic leukemia (CLL)
Research focus: Relapse Prevention (minimal residual disease)
Lina Benajiba, MD, PhD
INSERM Institute of Health and Medical Research
Grant awarded: 2022
Disease: Acute myeloid leukemia (AML)
Research focus: Cancer cell biology (microenvironment)
Robert Bowman, PhD
University of Pennsylvania, Perelman School of Medicine
Grant awarded: 2023
Disease: Acute myeloid leukemia (AML)
Research focus: Cancer cell biology
George Burslem, PhD
University of Pennsylvania
Grant awarded: 2021
Disease: Leukemia (AML, ALL)
Research focus: Causes/risk factors (epigenetics)
Xufeng Chen, PhD
New York University School of Medicine
Grant awarded: 2022
Disease: Leukemia (AML)
Research focus: Treatment (immunotherapy)
Matt Christopher, MD, PhD
Washington University, St.Louis
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Relapse prevention (maintenance therapy)
Leslie Crews, PhD
University of California, San Diego
Grant awarded: 2021
Disease: Multiple myeloma
Research focus: Cancer cell biology (cancer stem cells)
Marta Derecka, PhD
St. Jude Children's Research Hospital, Inc.
Grant awarded: 2023
Disease: Myelofibrosis
Research focus: Cell cancer biology
Ernesto Diaz-Flores, PhD
University of California, San Francisco
Grant awarded: 2021
Disease: Leukemia (ALL)
Research focus: Treatment (targeted therapy)
Cihangir Duy, MS, PhD
Fox Chase Cancer Center
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Cancer cell biology (leukemia cell biology)
Ann-Kathrin Eisfeld, MD
The Ohio State University
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Causes/risk factors (genetics)
Francesca Ferraro, MD, PhD
Washington University in St. Louis
Grant awarded: 2023
Disease: Acute myeloid leukemia (AML)
Research focus: Relapse prevention
Pietro Genovese, PhD
Dana-Farber Cancer Institute
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Treatment (immunotherapy)
Zhaohui Gu, PhD
Beckman Research Institute, City of Hope
Grant awarded: 2023
Disease: Acute lymphoblastic leukemia (ALL)
Research focus: Relapse prevention
Xue Han, PhD
The Ohio State University
Grant awarded: 2023
Disease: Acute myeloid leukemia (AML)
Research focus: Treatment
Md Kamrul Hasan, PhD
University of California, San Diego
Grant awarded: 2021
Disease: Leukemia (CLL)
Research focus: Cancer cell biology (microenvironment)
Christian Hurtz, PhD
Temple University
Grant awarded: 2022
Disease: Acute lymphoblastic leukemia (ALL)
Research focus: Treatment (targeted therapy)
Jo Ishizawa, MD, PhD
The University of Texas MD Anderson Cancer Center
Grant awarded: 2022
Disease: Leukemia (AML)
Research focus: Treatment (targeted therapy)
Max Jan, MD, PhD
Massachusetts General Hospital
Grant awarded: 2022
Disease: Leukemia (CLL)
Research focus: Treatment (immunotherapy)
Sangmoo Jeong, PhD
Johns Hopkins University
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Cancer cell biology (leukemia stem cells)
Qingfei Jiang, PhD
University of California, San Diego
Grant awarded: 2023
Disease: Acute lymphocytic leukemia (ALL)
Research focus: Treatment
Yoon-A Kang, PhD
Washington University in St. Louis
Grant awarded: 2022
Disease: Leukemia (MPNs)
Research focus: Causes/risk factors (MPNs)
Theodoros Karantanos, MD, PhD
Johns Hopkins University School of Medicine
Grant awarded: 2023
Disease: Acute myeloid leukemia (AML)
Research focus: Cancer cell biology
Anja Karlstaedt, MD, PhD
Cedars-Sinai Medical Center
Grant awarded: 2022
Disease: Leukemia (AML)
Research focus: Cancer cell biology (microenvironment)
David Kurtz, MD, PhD
Stanford University
Grant awarded: 2022
Disease: Multiple myeloma
Research focus: Treatment (immunotherapy)
Huacheng Luo, PhD
Pennsylvania State University
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Causes/risk factors (genetics)
Linde Miles, PhD
Cincinnati Children's Hospital Medical Center
Grant awarded: 2023
Disease: Acute myeloid leukemia (AML)
Research focus: Cancer cell biology
Laura Mondragon Martinez, PhD
Josep Carreras Leukaemia Research Institute
Grant awarded: 2022
Disease: Lymphoma (non-Hodgkin)
Research focus: Treatment (immunotherapy)
Joshua Riback, PhD
Baylor College of Medicine
Grant awarded: 2023
Disease: Acute myeloid leukemia (AML)
Research focus: Cancer cell biology
Christian Schuerch, PhD
University of Tübingen
Grant awarded: 2023
Disease: Acute myeloid leukemia (AML)
Research focus: Relapse prevention
Mithun Shah, MD, PhD
Mayo Clinic
Grant awarded: 2021
Disease: Leukemia (MDS)
Research focus: Cause/risk factors (MDS)
Alan Shih, MD, PhD
Icahn School of Medicine at Mount Sina
Grant awarded: 2023
Disease: Acute myeloid leukemia (AML)
Research focus: Cancer cell biology
Rui Su, PhD
Beckman Research Institute of the City of Hope
Grant awarded: 2022
Disease: Acute myeloid leukemia (AML)
Research focus: Cancer cell biology (leukemia stem cells)
Srividya Swaminathan, PhD
Beckman Research Institute, City of Hope
Grant awarded: 2023
Disease: Acute lymphoblastic leukemia (ALL)
Research focus: Treatment
Daniel Utzschneider, PhD
Peter Doherty Institute at the University of Melbourne
Grant awarded: 2023
Disease: Chronic lymphocytic leukemia (CLL)
Research focus: Treatment
Alexander Valvezan, PhD
Rutgers, The State University of New Jersey
Grant awarded: 2021
Disease: Leukemia (ALL)
Research focus: Treatment (targeted therapy)
Zhiquan Wang, PhD
Mayo Clinic - Rochester, Minnesota
Grant awarded: 2021
Disease: Chronic lymphocytic leukemia (CLL)
Research focus: Causes/risk factors (epigenetics)
Terrence Wong, MD, PhD
University of Michigan
Grant awarded: 2022
Disease: Leukemia (AML)
Research focus: Causes/risk factors (genetics)